Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PUBPAT and Chinese Innovators… My take on Texas Pacific, etc

Makes him neither

Pubpat can claim success when they get a nuance changed. Pohl can still claim success if the patent remains fundamentally unchanged.

Victory for all, one side far more hollow.

Regards

Share
New Message
Please login to post a reply